Boston Scientific Overview
Boston Scientific Target Price
Analysts' 12-month price predictions for BSX.
Get informed when a big investor buys or sells
+ FollowShare Price
$44.65
Average Target Price
$77.03
72.5% upside
72.5% upside29 analysts in the last 4 months
High: $100 | Low: $55
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-08 | NeedhamMike Matson | $57 | 27.7% upside |  |
| 2026-07-06 | Evercore ISI | $65 | 45.6% upside | |
| 2026-06-25 | Stifel Nicolaus | $65 | 45.6% upside | |
| 2026-06-12 | Piper Sandler | $65 | 45.6% upside | |
| 2026-06-04 | Truist Financial | $64 | 43.3% upside | |
| 2026-06-02 | BTIGMarie Thibault | $65 | 45.6% upside | |
| 2026-06-01 | Canaccord Genuity | $70 | 56.8% upside | |
| 2026-05-28 | Barclays | $89 | 99.3% upside | |
| 2026-05-28 | Wells FargoLarry Biegelsen | $55 | 23.2% upside | |
| 2026-05-28 | Leerink PartnersMike Kratky | $74 | 65.7% upside | |
| 2026-05-28 | Goldman Sachs | $71 | 59% upside | |
| 2026-05-28 | Robert W. Baird | $70 | 56.8% upside | |
| 2026-05-27 | Stifel NicolausRick Wise | $75 | 68% upside | |
| 2026-05-19 | Robert W. Baird | $75 | 68% upside | |
| 2026-04-29 | Daiwa | $60 | 34.4% upside | |
| 2026-04-23 | BarclaysMatt Miksic | $96 | 115% upside | |
| 2026-04-23 | Robert W. Baird | $78 | 74.7% upside | |
| 2026-04-23 | NeedhamMike Matson | $77 | 72.5% upside | |
| 2026-04-23 | Truist Financial | $85 | 90.4% upside | |
| 2026-04-23 | Canaccord GenuityWilliam Plovanic | $71 | 59% upside | |
| 2026-04-23 | RBC Capital | $100 | 124% upside | |
| 2026-04-23 | Wells Fargo | $75 | 68% upside | |
| 2026-04-23 | Oppenheimer | $90 | 101.6% upside | |
| 2026-04-22 | JefferiesMatthew Taylor | $100 | 124% upside | |
| 2026-04-22 | Goldman SachsDavid Roman | $84 | 88.1% upside | |
| 2026-04-21 | Stifel NicolausRick Wise | $85 | 90.4% upside | |
| 2026-04-15 | Truist Financial | $90 | 101.6% upside | |
| 2026-04-13 | Mizuho Securities | $90 | 101.6% upside | |
| 2026-03-26 | Goldman Sachs | $93 | 108.3% upside | |
| 2026-02-17 | Canaccord GenuityWilliam Plovanic | $109 | 144.1% upside | |
| 2026-02-06 | BernsteinLee Hambright | $112 | 150.8% upside | |
| 2026-02-05 | Truist Financial | $95 | 112.8% upside | |
| 2026-02-05 | Canaccord GenuityWilliam Plovanic | $112 | 150.8% upside | |
| 2026-02-05 | UBS | $120 | 168.8% upside | |
| 2026-02-05 | Robert W. Baird | $101 | 126.2% upside | |
| 2026-02-05 | Goldman Sachs | $99 | 121.7% upside | |
| 2026-02-05 | Wells Fargo | $94 | 110.5% upside | |
| 2026-02-05 | Evercore ISI | $96 | 115% upside | |
| 2026-02-05 | Mizuho Securities | $115 | 157.6% upside | |
| 2026-02-05 | Needham | $97 | 117.2% upside | |
| 2026-02-05 | RBC Capital | $115 | 157.6% upside | |
| 2026-02-04 | Stifel NicolausRick Wise | $110 | 146.4% upside | |
| 2026-02-04 | BTIG | $110 | 146.4% upside | |
| 2026-02-03 | Barclays | $124 | 177.7% upside | |
| 2026-02-02 | National Bank | $115 | 157.6% upside | |
| 2026-01-16 | Oppenheimer | $100 | 124% upside | |
| 2026-01-09 | Goldman SachsDavid Roman | $112 | 150.8% upside | |
| 2026-01-05 | Evercore ISI | $112 | 150.8% upside | |
| 2025-12-18 | Truist Financial | $120 | 168.8% upside | |
| 2025-12-17 | RBC Capital | $130 | 191.2% upside | |